These results, together with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 help the principle of targeting ACKR3 as a unique technique to modulate the opioid procedure, which could open new therapeutic avenues for opioid-linked Problems. These final results suggest that conolidine https://freemans692cyv2.blogcudinti.com/profile